# Chronic Pulmonary Aspergillosis: Genomic Variant Analysis and Protein Dysfunction Susceptibility in a Brazilian Cohort

**Authors:** Rafaela da Silva Mendes, Beatriz Martins Wolff, Mariana Ribeiro Costa Siemann, Yanca Gasparini Oliveira, Gleyson Francisco da Silva Carvalho, Lucas Liro Vieira, Eder Alencar Moura, Karina Marinho Nascimento, Lissandro de Sousa Rolim, Andre Nathan Costa, Marcello Mihailenko Chaves Magri, Vítor Falcão de Oliveira, Leslie Domenici Kulikowski

PMC · DOI: 10.3390/genes16060676 · Genes · 2025-05-30

## TL;DR

This study explores genetic variants in Brazilian patients with chronic pulmonary aspergillosis to understand their role in immune dysfunction and disease susceptibility.

## Contribution

The first use of a custom multigenic panel to investigate CPA susceptibility in a Brazilian cohort.

## Key findings

- SNVs in genes like CX3CR1, IL12B, and IL4R were identified as variants of uncertain significance.
- Protein–protein interaction analysis suggests these variants may contribute to immune evasion and dysfunction.
- The study highlights the potential for future functional and clinical research in fungal immunogenetics.

## Abstract

Background/Objectives: Chronic pulmonary aspergillosis (CPA) is a debilitating condition often affecting immunocompetent patients with underlying structural lung diseases, particularly pulmonary tuberculosis. This study investigates single nucleotide variants (SNVs) in immunogenetic-related genes among a Brazilian cohort with CPA. Methods: Twelve patients with confirmed CPA, based on ESCMID/ERS criteria, were sequenced using custom multigenic panel sequencing. Variants were annotated, classified using ACMG guidelines, and analyzed for potential impact on protein interactions and immune pathways. Results: A set of SNVs in CX3CR1, IL12B, IL4R, PTX3, CCR5, and IFNG genes were classified as variants of uncertain significance (VUS), but protein–protein interaction analysis suggests a potential role in immune evasion and dysfunction. Conclusions: This is the first study to apply a custom multigenic panel for CPA susceptibility in a Brazilian cohort, contributing to future functional and clinical studies in fungal immunogenetics.

## Linked entities

- **Genes:** CX3CR1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 1524], IL12B (interleukin 12B) [NCBI Gene 3593], IL4R (interleukin 4 receptor) [NCBI Gene 3566], PTX3 (pentraxin 3) [NCBI Gene 5806], CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234], IFNG (interferon gamma) [NCBI Gene 3458]
- **Diseases:** pulmonary tuberculosis (MONDO:0006052)

## Full-text entities

- **Genes:** CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234] {aka CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5}, CX3CR1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 1524] {aka CCRL1, CMKBRL1, CMKDR1, GPR13, GPRV28, V28}, PTX3 (pentraxin 3) [NCBI Gene 5806] {aka TNFAIP5, TSG-14}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, IL4R (interleukin 4 receptor) [NCBI Gene 3566] {aka CD124, IL-4RA, IL4RA}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}
- **Diseases:** lung diseases (MESH:D008171), CPA (MESH:D055744), Protein Dysfunction (MESH:D001796), pulmonary tuberculosis (MESH:D014397), fungal (MESH:D009181)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12193534/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12193534/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12193534/full.md

---
Source: https://tomesphere.com/paper/PMC12193534